Debora A. Jorn
Overview
Debora A. Jorn received an average of $3M in total compensation, including $442K in salary, at Valeant Pharmaceuticals International from 2013 to 2015.
Source: SEC filing on April 29, 2016.
Related executives
We found 27 more executives who work or worked at Valeant Pharmaceuticals International.
Joseph Papa
Valeant Pharmaceuticals International
Chief Executive Officer
Thomas Appio
Valeant Pharmaceuticals International
President Co, Head Bausch + Lomb/International
Paul Herendeen
Valeant Pharmaceuticals International
Chief Financial Officer
Christina Ackermann
Valeant Pharmaceuticals International
General Counsel
Sam Eldessouky
Valeant Pharmaceuticals International
Chief Financial Officer
Robert Spurr
Valeant Pharmaceuticals International
President, U.S. Pharma Business
Joseph Gordon
Valeant Pharmaceuticals International
President & Co, Head, Bausch + Lomb/International
William Humphries
Valeant Pharmaceuticals International